Akzo Nobel India Financial Statements

Akzo Nobel India (AKZOINDIA) reported revenue of ₹41.19B in FY2025 with net income of ₹4.29B. Total assets stood at ₹29.03B and free cash flow was ₹2.05B.

Akzo Nobel India Income Statement

Hover the chart icon for year-over-year change.

FY 2021 – FY 2025

Item	Chart	2021	2022	2023	2024	2025
Revenue		24.45B	31.71B	38.30B	39.97B	41.19B
Cost of Rev. Cost of Revenue		-13.23B	-18.78B	-22.90B	-22.23B	-23.18B
Gross Profit		11.22B	12.93B	15.39B	17.75B	18.01B
SGA Sales, General & Admin		-7.58B	-8.38B	-9.87B	-11.07B	-11.32B
Op. Income Operating Income		2.89B	3.79B	4.70B	5.85B	5.80B
PBT Profit Before Tax		2.78B	3.67B	4.56B	5.73B	5.70B
Net Income		2.08B	2.90B	3.35B	4.27B	4.29B
Dil. Shares Diluted Shares		45.54M	45.54M	45.54M	45.54M	45.54M
Diluted EPS		45.59	63.70	73.58	93.68	94.31

Figures in ₹ — millions (M), billions (B), trillions (T). EPS is earnings per share.

Understanding the Income Statement

The income statement shows Akzo Nobel India's revenue and expenses over a period. Revenue minus costs gives gross profit; after operating expenses, interest, and taxes, the remainder is net income. Diluted EPS divides net income by all shares that could exist if options and convertibles were exercised.

Akzo Nobel India Balance Sheet

Hover the chart icon for year-over-year change.

FY 2021 – FY 2025

Item	Chart	2021	2022	2023	2024	2025
Curr. assets Total current assets		17.48B	17.60B	18.68B	19.22B	16.72B
Non-curr. assets Total non-current assets		7.82B	8.31B	8.72B	9.82B	12.31B
Total assets		25.30B	25.92B	27.41B	29.04B	29.03B
Curr. liabilities Total current liabilities		10.91B	11.84B	12.64B	14.24B	14.50B
Non-curr. liab. Total non-current liabilities		1.51B	1.48B	1.60B	1.51B	1.23B
Total liabilities		12.42B	13.32B	14.24B	15.74B	15.73B
Total equity		12.88B	12.60B	13.16B	13.30B	13.30B
Total liab. & eq. Total liabilities & equity		25.30B	25.92B	27.41B	29.04B	29.03B

Figures in ₹ — millions (M), billions (B), trillions (T).

Understanding the Balance Sheet

The balance sheet captures Akzo Nobel India's financial position at a point in time — what it owns (assets), what it owes (liabilities), and the residual value to shareholders (equity). Total assets always equals total liabilities plus equity.

Akzo Nobel India Cash Flow Statement

Hover the chart icon for year-over-year change.

FY 2021 – FY 2025

Item	Chart	2021	2022	2023	2024	2025
Net Income		2.78B	3.67B	4.56B	5.73B	5.70B
Operating CF Cash flow Operating Activities		2.83B	1.21B	4.86B	4.86B	3.11B
Capex Investments in PPE		-281.00M	-634.00M	-1.04B	-1.19B	-1.07B
Investing CF Cash flow Investing Activities		-2.25B	2.30B	-151.00M	-860.00M	1.23B
Dividend Paid		-1.55B	-3.19B	-2.73B	-4.10B	-4.33B
Financing CF Cash flow Financing Activities		-1.74B	-3.46B	-3.02B	-4.39B	-4.60B
Cash (start) Cash at beginning of period		2.55B	1.39B	1.45B	3.15B	2.74B
Cash (end) Cash at end of period		1.39B	1.45B	3.15B	2.74B	2.48B
FCF Free Cash Flow		2.55B	580.00M	3.82B	3.67B	2.05B

Figures in ₹ — millions (M), billions (B), trillions (T).

Understanding Cash Flow

The cash flow statement tracks how Akzo Nobel India's cash moves through operations, investing, and financing activities. Free cash flow — operating cash minus capital expenditure — shows what is available to return to shareholders.

Data from audited consolidated filings. For educational purposes only — not investment advice. Last update: Mar-2025